Posted by AGORACOM-JC
at 5:22 PM on Monday, March 16th, 2020
SPONSOR: Datametrex AI Limited
(TSX-V: DM) A revenue generating small cap A.I. company that NATO and
Canadian Defence are using to fight fake news & social media
threats. The company announced three $1M contacts in Q3-2019. Click here for more info.
Synthetic media: The real trouble with deepfakes
By M. Mitchell Waldrop
The snapshots above look like people you’d know. Your daughter’s best friend from college, maybe? That guy from human resources at work? The emergency-room doctor who took care of your sprained ankle? One of the kids from down the street?
“Deepfakes play to our weaknesses,†explains Jennifer Kavanagh, a political scientist at the RAND Corporation and coauthor of “Truth Decay,â€
Nope. All of these images are “deepfakes†— the nickname for
computer-generated, photorealistic media created via cutting-edge
artificial intelligence technology. They are just one example of what
this fast-evolving method can do. (You could create synthetic images
yourself at ThisPersonDoesNotExist.com.) Hobbyists, for example, have used the same AI techniques to populate YouTube with a host of startlingly lifelike video spoofs
— the kind that show real people such as Barack Obama or Vladimir Putin
doing or saying goofy things they never did or said, or that revise
famous movie scenes to give actors like Amy Adams or Sharon Stone the
face of Nicolas Cage. All the hobbyists need is a PC with a high-end
graphics chip, and maybe 48 hours of processing time.
It’s good fun, not to mention jaw-droppingly impressive. And coming
down the line are some equally remarkable applications that could make
quick work out of once-painstaking tasks: filling in gaps and scratches
in damaged images or video; turning satellite photos into maps; creating
realistic streetscape videos to train autonomous vehicles; giving a
natural-sounding voice to those who have lost their own; turning
Hollywood actors into their older or younger selves; and much more.
Deepfake artificial-intelligence methods can map the face of, say,
actor Nicolas Cage onto anyone else — in this case, actor Amy Adams in
the film Man of Steel.
Yet this technology has an obvious — and potentially enormous — dark
side. Witness the many denunciations of deepfakes as a menace,
Facebook’s decision in January to ban (some) deepfakes outright and
Twitter’s announcement a month later that it would follow suit.
“Deepfakes play to our weaknesses,†explains Jennifer Kavanagh, a political scientist at the RAND Corporation and coauthor of “Truth Decay,â€
a 2018 RAND report about the diminishing role of facts and data in
public discourse. When we see a doctored video that looks utterly real,
she says, “it’s really hard for our brains to disentangle whether that’s
true or false.†And the internet being what it is, there are any number
of online scammers, partisan zealots, state-sponsored hackers and other
bad actors eager to take advantage of that fact.
“The threat here is not, ‘Oh, we have fake content!’†says Hany
Farid, a computer scientist at the University of California, Berkeley,
and author of an overview of image forensics in the 2019 Annual Review of Vision Science.
Media manipulation has been around forever. “The threat is the
democratization of Hollywood-style technology that can create really
compelling fake content.†It’s photorealism that requires no skill or
effort, he says, coupled with a social-media ecosystem that can spread
that content around the world with a mouse click.
Posted by AGORACOM-JC
at 4:43 PM on Monday, March 16th, 2020
SPONSOR: BetterU Education Corp.
aims to provide access to quality education from around the world. The
company plans to bridge the prevailing gap in the education and job
industry and enhance the lives of its prospective learners by developing
an integrated ecosystem. Click here for more information.
Can coronavirus do for edtech what demonetisation did for digital payments in India?
The Covid-19 pandemic has forced several schools and colleges across India to temporarily close. In Delhi alone, over two million kids are being forced to stay at home with primary schools shut until March 31.
With fresh cases being reported each day, there are expectations that more schools and colleges will be closed in the coming weeks.
On Nov. 8, 2016, digital payments companies became mainstream in India overnight
after the government suddenly decided to demonetise two high-value
currency notes. Now, education technology (edtech) firms are hoping for
an encore in the wake of the coronavirus outbreak.
The Covid-19 pandemic has forced several schools and colleges across India to temporarily close. In Delhi alone, over two million kids
are being forced to stay at home with primary schools shut until March
31. With fresh cases being reported each day, there are expectations
that more schools and colleges will be closed in the coming weeks.
Edtech companies are jumping to make the most of the situation,
offering free access to their courses during a time that typically flags
off the exam season.
But overnight success might be hard to come for these platforms, experts said.
“While a smartphone is good enough for browsing, social media, and so
on, for studies, assignments, and projects, it doesn’t suffice,â€
Prateek Shukla, CEO & co-founder Bengaluru-based coding bootcamp
Masai School, told Quartz. “A stable internet and electricity connection
is the biggest challenge.†Power outages are still very frequent across
most Indian cities, especially in smaller towns.
And that is just one of the many hurdles. Companies, though, are going all out to make hay.
Wooing India
On March 11, Bengaluru-based Byju’s, the world’s biggest edtech firm,
said it was making all its learning programmes for students in classes 1
through 12 free until April-end. Soon after, rival Toppr offered free
access to its live and video classes for school kids until March 31, and
Unacademy announced 20,000 free live classes for candidates looking to
prep for entrance exams for union public service commission, banking,
railways, and more.
“We want learners to utilise this time…We will support the education
system in every way possible to weather the storm,†said Gaurav Munjal,
co-founder and CEO of Unacademy. Toppr said it will consider extending
the free access for students if schools don’t reopen after March.
Edtech is already well equipped to handle a possible surge in demand,
said Akash Singhal, founder & CEO of edtech startup Illumnus.
Teachers producing online lessons have already been working remotely, so
there is no additional cost in producing lessons.
The initiatives are already bringing in gains.
Noida-based Gradeup has seen a 25% uptick in daily enrolments since
it doubled the number of free video on its platform in light of the
coronavirus outbreak.
Posted by AGORACOM-JC
at 9:32 AM on Monday, March 16th, 2020
Received its standard cultivation licence from Health Canada for 24,500 sq. ft. of indoor cannabis cultivation space at its purpose-built cannabis production facility located on 135 acres of agricultural land in Low, Quebec
Receipt of this licence allows the Company to proceed with phase one (indoor cultivation) at its Quebec Facility.
Company will soon be filing an amendment application with Health Canada to licence an additional 1,000,000 sq. ft. of outdoor cultivation space
TORONTO, March 16, 2020 – North Bud Farms Inc. (CSE: NBUD) (OTCQB: NOBDF) (“NORTHBUD” or the “Company“) is pleased to announce that its wholly-owned subsidiary, GrowPros MMP Inc., has received its standard cultivation licence from Health Canada for 24,500 sq. ft. of indoor cannabis cultivation space at its purpose-built cannabis production facility located on 135 acres of agricultural land in Low, Quebec (the “Quebec Facilityâ€).  The receipt of this licence allows the Company to proceed with phase one (indoor cultivation) at its Quebec Facility.
Highlights:
Cultivation is expected to begin
shortly with the first four months focused on establishing an inventory
of mother plants and clones in preparation for the outdoor growing
season that begins in late June;
The Company will soon be filing an
amendment application with Health Canada to licence an additional
1,000,000 sq. ft. of outdoor cultivation space, which it hopes will be
approved in the second quarter of 2020. Operationalizing the outdoor
cultivation space represents phase two of the Company’s strategy for its
Quebec Facility;
The Company expects the operation of
the Quebec Facility to create approximately 25 local jobs in the
Gatineau Valley region of Quebec; and
Upon full operation of both the indoor
and expected outdoor cultivation space at the Quebec Facility, the
annual production is estimated to be up to 20,000,000 grams per year.
“We are extremely excited about this
announcement as it represents another significant step forward in
NORTHBUD’s strategy to assemble a portfolio of cost-efficient
cultivation facilities located in strategic jurisdictions,†said Sean
Homuth, CEO of NORTHBUD. “The receipt of our Canadian licence now gives
us active licensed facilities in California, Nevada and Canada, three
of the largest and most important recreational cannabis markets in the
world. These facilities will be used for the production of NORTHBUD
branded cannabis products to be sold in all three of those key
jurisdictions.â€
“I would like to thank our shareholders for
their support over the past 18 months, as well as our team for their
hard work and dedication, particularly the work of Magda Farid, our Vice
President of Compliance and Quality Assurance, and Kyle Foley, our Head
of Facilities Management, both of whom have been instrumental in
achieving this milestone,†said Ryan Brown, Executive Chairman of
NORTHBUD and CEO of GrowPros MMP Inc. “We are very proud to be the
second licensed producer in the Outaouais region of Quebec. The
culmination of this project is not only important for the Company but
also for the economy of the local town of Venosta, Quebec, and we look
forward to strengthening our relationship with our local community as we
move into the operational phase with the Quebec Facility.â€
Board of Director Change Effective
March 9, 2020, Michael Saxon has resigned from the Company’s Board of
Directors due to requirements related to his new employment elsewhere.
“I want to sincerely thank Michael for his
direction and guidance since the inception of the Company and wish him
well with his new role and future endeavors,†said Ryan Brown, Executive
Chairman.
About North Bud Farms Inc. North
Bud Farms Inc. owns and operates, through its subsidiaries, licensed
cannabis facilities in Canada, California and Nevada. Bonfire Brands
USA, the Company’s U.S. subsidiary, acquired cannabis production
facilities in Salinas, California and Reno, Nevada in late 2019. The
Salinas, California 11-acre farm is actively cultivating cannabis in its
60,000 sq. ft. of licensed greenhouse production space. The Reno,
Nevada facility, located on 3.2 acres of land, was acquired through the
acquisition of Nevada Botanical Science, Inc., and includes a
world-class cannabis production, research and development facility with
5,000 sq. ft. of indoor cultivation space which holds medical and
adult-use licenses for cultivation, extraction and distribution.
Through its wholly-owned Canadian subsidiary, GrowPros MMP Inc., the
Company built and owns a state-of-the-art purpose-built cannabis
production facility located on 135 acres of agricultural land in Low,
Quebec, Canada. The Low, Quebec facility currently has 24,500 sq. ft.
of licensed indoor cultivation space; the Company expects to submit its
licence application to Health Canada for an additional 1,000,000 sq. ft.
of outdoor cultivation space in the near future.
Neither the Canadian Securities Exchange (the “CSE“)
nor its Regulation Services Provider (as that term is defined in the
policies of the CSE) accepts responsibility for the adequacy or accuracy
of this release.
Forward-looking statements Certain
statements and information included in this press release that, to the
extent they are not historical fact, constitute forward-looking
information or statements (collectively, “forward-looking statementsâ€)
within the meaning of applicable securities legislation.
Forward-looking statements, include but are not limited to those
identified by the expressions “anticipateâ€, “believeâ€, “planâ€,
“estimateâ€, “expectâ€, “intendâ€, “mayâ€, “should†and similar expressions
to the extent they relate to the Company or its management.
Forward-looking statements, including but
not limited to, the status of any of the Company’s current or future
licence applications with Health Canada under the Cannabis Act, the
Company’s ability to execute its strategic plan, conditions in the
cannabis market, the Company entering agreements in connection with the
B2B supply of cannabis and the Company’s transition into a
revenue-generating operational phase of development are based on the
reasonable assumptions, estimates, analysis and opinions of management
made in light of its experience and its perception of trends, current
conditions and expected developments, as well as other factors that
management believes to be relevant and reasonable in the circumstances
at the date that such statements are made, but which may prove to be
incorrect.
Forward-looking statements involve known and
unknown risks, uncertainties and other factors that may cause the
actual results, performance or achievements of the Company to differ
materially from any future results, performance or achievements
expressed or implied by the forward-looking statements. Such risks and
uncertainties include, among others, the risk factors included in the
Company’s final long form prospectus dated August 21, 2018, which is
available under the Company’s SEDAR profile at www.sedar.com.
Accordingly, readers should not place undue reliance on any such
forward-looking statements. Further, any forward-looking statement
speaks only as of the date on which such statement is made. New factors
emerge from time to time, and it is not possible for the Company’s
management to predict all of such factors and to assess in advance the
impact of each such factor on the Company’s business or the extent to
which any factor, or combination of factors, may cause actual results to
differ materially from those contained in any forward-looking
statements. The Company does not undertake any obligation to update any
forward-looking statements to reflect information, events, results,
circumstances or otherwise after the date hereof or to reflect the
occurrence of unanticipated events, except as required by law including
securities laws. This news release does not constitute an offer to sell
or a solicitation of any offer to buy any securities of the Company.
FOR ADDITIONAL INFORMATION, PLEASE CONTACT: North Bud Farms Inc. Edward Miller VP, IR & Communications Office: (855) 628-3420 ext. 3 [email protected]
Posted by AGORACOM-JC
at 7:00 PM on Sunday, March 15th, 2020
Until now, investor participation in Artificial Intelligence has been the domain of mega companies and those funded by Silicon Valley. Small cap investors can finally consider participating in the great future of A.I. through Datametrex AI (DM: TSXV) (Soon To Be Nexaology) who has achieved the following over the past few months:
Q3 Revenues Of $1.6 million, an increase of 186%
9 Month Revenues Of $2.56M an increase of 37%
Repeat Contracts Of $1M and $600,000 With Korean Giant LOTTE
$954,000 Contract With Canadian Department of Defence To Fight Social Media Election Meddling
Participation In NATO Research Task Group On Social Media Threat Detection
When a small cap Artificial Intelligence company is successfully
deploying its technology with military and conglomerates, smart
investors have to take a closer look.
That look can begin with our latest interview of Datametrex CEO,
Marshall Gunter, who talks to us about the use of the Company’s
Artificial Intelligence to discover and eliminate US Presidential
election meddling. The fake news isn’t just targeting candidates
specifically, it also targets wedge issues such as abortion cases now
before the US Supreme Court and even the Coronavirus.
Watch this interview on one of your favourite screens or hit play and listen to the audio as you drive.
Posted by AGORACOM
at 5:33 PM on Friday, March 13th, 2020
VANCOUVER, BC / March 13, 2020 / Mota Ventures Corp. (CSE:MOTA)(FSE:1WZ1)(OTC:PEMTF) (the “Company“)
is excited to announce that for the month of February 2020, its First
Class CBD brand achieved sales of Cdn$2,981,000, with related expenses
for the same time period totaling Cdn$2,814,000. Due to accelerated
marketing efforts in late January 2020, the brand was able to improve
gross margins by 4.9% from January 2020 to February 2020. The Company
anticipates these efforts will yield a further positive impact on
revenue and margin in subsequent months. Sales for February 2019 were
Cdn$320,000; therefore, February 2020 represents an increase of 832%
over the same period last year.
First Class offers a CBD hemp-oil formulation intended to provide
users with the therapeutic benefits that hemp may offer. The hemp oil
used in the products is derived from hemp grown and cultivated in the
United States. The extraction process is designed to maintain all the
beneficial qualities that hemp may offer. First Class offers a range of
products, which include CBD oil drops, CBD gummies, CBD pain relief
cream, CBD skin serum and CBD coffee. The Company plans to continue
growth of First Class in the United States over the balance of 2020, as
well as an expansion into the European market.
“I am extremely pleased with the performance of the First Class brand
through the beginning months of 2020. The continued growth we are
experiencing is evidence of the strong consumer demand in the CBD
market. While eCommerce demand is generally weakest in January and
February, we continue to demonstrate our leadership through achieving
approximately Cdn$5,874,000 in revenue through the first two months of
the year,” stated Ryan Hoggan, CEO of the Company.
The Company cautions that figures for revenue, expenses and margin
generated from the sale of First Class CBD products have not been
audited, and are based on calculations prepared by management. Actual
results may differ from those reported in this release once these
figures have been audited. These figures were translated from US dollar
into Canadian dollar using the Bank of Canada monthly average exchange
rates of 1.3301 for January 2019, 1.3206 for February 2019, 1.3087 for
January 2020 and 1.3286 for February 2020.
About Mota Ventures Corp.
Mota Ventures is seeking to become a vertically integrated global CBD
brand. Its plan is to cultivate and extract CBD into high-quality value
added products from its Latin American operations and distribute it
both domestically and internationally. Mota has established distribution
networks through the acquisition of First Class CBD in the United
States and Sativida in Europe. Mota Ventures is also seeking to acquire
revenue producing CBD brands and operations in both Europe and North
America, with the goal of establishing an international distribution
network for CBD products. Low cost production, coupled with
international, direct to customer, sales channels will provide the
foundation for the success of Mota Ventures.
ON BEHALF OF THE BOARD OF DIRECTORS
MOTA VENTURES CORP.
Ryan Hoggan Chief Executive Officer
For further information, readers are encouraged to contact Joel Shacker, President at +604.423.4733 or by email at [email protected] or www.motaventuresco.com
During a normal flu season, frequent weed smokers know the drill.
Pay closer attention to everyone’s cough patterns during a smoke
sesh. Stop accepting mouth-wet blunts from strangers. And if you think
you’re coming down with something, wave a lighter under the mouthpiece
before passing the pipe.
This year, obviously, things are a bit more serious. We’re dealing
with multiple citywide quarantines, global economic disruption, and a
pandemic being compared to the damn Spanish flu. It’s enough to make
self-respecting cannabis enthusiasts re-evaluate their medicine cabinet
and diversify their stash box.
Obviously, there’s no dependable research on CBD’s or THC’s effect on
COVID-19. But we do know a few things about cannabis and general
wellness. Down the rabbit hole of alternative cannabinoids and
non-psychoactive cannabis, there is a wealth of potential medicinal
benefits both preventative and curative.
At least when it comes to the regular flu, CBD has been found to help
support immune systems, ease symptoms, and replace over-the-counter
pain relievers, sleep aids, and medicated salves currently taking up
space in our medicine cabinet. But not just any CBD will do, and CBD
alone won’t do it all.
Obviously, the best course of action right now is to keep vigorously
washing your hands, mind your coughs, avoid large crowds, and be a bit
more stingy with your pipes and joints. But if you find yourself
slipping under the weather, for whatever reason, here are a few things
to know about how cannabis might help ease symptoms.
CBD for Immune System Support
Tons more research is required to accurately map the relationship
between the immune and endocannabinoid systems, but it’s well
established that CBD helps reduce self-harming autoimmune and
inflammatory responses. “CBD has been found to act as an immune system
modulator,” says Anna Symonds, director of East Fork Cultivars’ CBD
Certified program. “This means that it’s like a thermostat—it can turn
the level of activity down or up, depending on the body’s needs.”
Tags: CSE, Hemp, Marijuana, small cap, small cap stocks, stocks Posted in Empower Clinics Inc. | Comments Off on Empower Clinics $CBDT.ca – #Cannabis Won’t Cure #Coronavirus, but It Can Help Ease Certain Flu Symptoms $WEED.ca $CGC $ACB $APH $CRON.ca $HEXO.ca $OGI.ca
Posted by AGORACOM-JC
at 4:13 PM on Friday, March 13th, 2020
SPONSOR: Datametrex AI Limited
(TSX-V: DM) A revenue generating small cap A.I. company that NATO and
Canadian Defence are using to fight fake news & social media
threats. The company announced three $1M contacts in Q3-2019. Click here for more info.
As videos faked using artificial intelligence grow increasingly
sophisticated, experts in Switzerland are re-evaluating the risks its
malicious use poses to society – and finding innovative ways to stop the
perpetrators.
In a computer lab on the vast campus of the Swiss Federal Institute
of Technology Lausanne (EPFL), a small team of engineers is
contemplating the image of a smiling, bespectacled man boasting a rosy
complexion and dark curls.
“Yes, that’s a good one,†says lead researcher Touradj Ebrahimi, who
bears a passing resemblance to the man on the screen. The team has
expertly manipulated Ebrahimi’s head shot with an online image of Tesla
founder Elon Musk to create a deepfake – a digital image or
video fabricated through artificial intelligence.
It’s one of many fake illustrations – some more realistic than others – that Ebrahimi’s teamexternal link has created as they develop software, together with cyber security firm Quantum Integrityexternal link (QI), which can detect doctored images, including deepfakes.
Using machine learning, the same process behind the creation of
deepfakes, the software is learning to tell the difference between the
genuine and the forged: a “creator†feeds it fake images, which a
“detector†then tries to find.
“With lots of training, machines can help to detect forgery the same
way a human would,†explains Ebrahimi. “The more it’s used, the better
it becomes.â€
Forged photos and videos have existed since the advent of multimedia.
But AI techniques have only recently allowed forgers to alter faces in a
video or make it appear the person is saying something they never did.
Over the last few years, deepfake technology has spread faster than most
experts anticipated.
The team at EPFL have created the image in the centre by using deep
learning techniques to alter the headshot of Ebrahimi (right) and a
low-resolution image of Elon Musk in profile found on the
Internet.​​​​​​​
(EPFL/MMSPG/swissinfo)
“Precisely because it is moving so fast, we need to map where this
could go – what sectors, groups and countries might be affected,†says
its deputy director, Aengus Collins.
Although much of the problem with malign deepfakes involves their use
in pornography, there is growing urgency to prepare for cases in which
the same techniques are used to manipulate public opinion.
A fast-moving field
When Ebrahimi first began working with QI on detection software three
years ago, deepfakes were not on the radar of most researchers. At the
time, QI’s clients were concerned about doctored pictures of accidents
used in fraudulent car and home insurance claims. By 2019, however,
deepfakes had developed a level of sophistication that the project
decided to dedicate much more time to the issue.
“I am surprised, as I didn’t think [the technology] would move so fast,†says Anthony Sahakian, QI chief executive.
Sahakian has seen firsthand just how far deepfake techniques have
come to achieve realistic results, most recently the swapping of faces
on a passport photo that manages to leave all the document seals intact.
Posted by AGORACOM
at 11:13 PM on Thursday, March 12th, 2020
Vertical Exploration is developing its St. Onge Wollastonite as a soil additive for optimizing marijuana growth. Recently engaged AGRINOVA’s Phase 1 Reseach program also demonstrated Wollastonite can potentially become BNQ certified for agricultural use in Quebec. Recently signed distribution agreement with AREV Brands International to Supply St-Onge Wollastonite to the Cannabis and Hemp Industries. Click Here for More Info.
Definitive
distribution agreement to partner on the sale of Vertical’s
wollastonite from its world-class St-Onge Deposit in place.
Supplying the fast growing cannabis and hemp industries.
Vertical’s high quality Wollastonite has been shown to be beneficial to cannabis plants in a variety of ways
In every case the most optimal results occurred with an admixture rate of 10% to 15% wollastonite to the growth medium.
The
high-grade St-Onge Wollastonite deposit has pit-constrained mineral
resources of: 7,155,000 tonnes Measured@ 36.20% Wollastonite &
6,926,000 tonnes Indicated@ 37.04%
B.C. Buds Testing Confirmed Wollastonite is critical to marijuana growers
Engaged
AGRINOVA over the past year to conduct research and testing of
Vertical’s St-Onge wollastonite on a range of important agricultural end
uses.
WOLLASTONITE
St-Onge-Wollastonite
Deposit located approximately 90 kilometres Northwest of the city of
Saguenay, in St-Onge township, in the Saguenay-Lac-St-Jean region of
Quebec, Canada.
Research and testing in the Phase 1 program for use in cannabis growth was managed and monitored by AGRINOVA, a highly-regarded Center for Research and Innovation in Agriculture in Quebec
Posted by AGORACOM-JC
at 6:12 PM on Thursday, March 12th, 2020
SPONSOR: CardioComm Solutions (EKG: TSX-V)
– The heartbeat of cardiovascular medicine and telemedicine. Patented
systems enable medical professionals, patients, and other healthcare
professionals, clinics, hospitals and call centres to access and manage
patient information in a secure and reliable environment.
Coronavirus Scare Gives Telehealth an Opening to Redefine Healthcare
With the coronavirus threatening to become a pandemic, health
systems and telehealth vendors see this as an opportunity to bring
connected health to the forefront – and reshape the future of
healthcare.
Most see the exercise as an extension of their preparations for flu
season. Some see this as an opportunity to lobby for telehealth adoption
across the board, saying a possible epidemic offers ample evidence of
the value of telehealth and mHealth.
Defining Telehealth’s Value in a Changing Landscape
“COVID-19 is different because we do not know all the factors
surrounding transmission and its effects on patients,†Jason Hallock,
Chief Medical Officer for SOC Telemed, points out. “Because coronavirus
is new and there have been a significant number of deaths, the
uncertainty surrounding that is scaring both patients and the general
public. Our healthcare workers do not have all the answers
yet. Telehealth providers are challenged to make recommendations when
there are still many unknowns. Telemedicine can be useful to evaluate
and reassure patients in alternative settings, and also can be used to
help patients decide who needs to be seen in the hospital or an
alternative setting like an urgent care.â€
Hallock says telehealth can help by enabling healthcare providers to
treat isolated patients, thus preventing the spread of what has so far
been an extremely contagious virus.
In a Q&A with mHealthIntelligence, Peter Antall, MD,
President and Chief Medical Officer for American Well, offered an
in-depth take on how telehealth might be used.
Q. Telehealth has long been seen as an ideal means of
expediting care during flu outbreaks. How is the coronavirus scare
different? Does this pose any unique challenges that telehealth can
address?
A. The novel coronavirus, or COVID-19, is similar to
influenza in how it is transmitted (airborne), how symptoms manifest
themselves, and the fear it stirs among those individuals at risk. When
evaluating patients through telehealth, we use similar methodology as
that used for influenza, except that the current Centers for Disease
Control and Prevention (CDC) recommendations call for risk
stratification based on known exposure or travel to endemic areas and
referral for testing for those at high risk or those who are sick enough
to need hospital care. Also, unlike with influenza, there are no
current specific treatments, like antivirals, for the coronavirus at
this time.
If local person-to-person spread expands to wide community spread, we
expect care will need to evolve to a method that is quite similar to
how we treat influenza today. Under those circumstances, we will likely
begin diagnosing coronavirus-like illness (CLI) on a clinical basis,
without testing. We would likely then only be expected to refer
inpatients with CLI who need hospital care clinically, while those with
milder symptoms will likely be treated and monitored at home so as to
limit the spread of this disease and not overwhelm our healthcare
facilities.
In this way, telehealth is an ideal venue for an outbreak like this.
We can increase access to care. We can offer care that is commensurate
with the acuity and nature of the symptoms and make referrals as needed.
This helps with infection prevention and control and also allows
patients to receive their care in the home without exposing themselves
to further illness.
One other notable point is the potential for telehealth to help in
providing routine care for other conditions and offset coronavirus fears
in the . Patients have other healthcare needs unrelated to coronavirus,
but many are afraid to go to healthcare settings for fear of catching
disease. This has begun to result in a migration of patients to
telehealth. For example, on February 25, we saw telehealth urgent care
patient volume that was 11 percent higher than expected. Many patients
are now sharing anecdotes indicating they were afraid to sit in a
waiting room, so they used telehealth instead.
Q. Are there new tools or technologies available that can be useful in dealing with the coronavirus?
A. Telehealth itself is a tool in this fight. Keep
in mind that there are many varieties of telehealth. It can be used to
connect a doctor or other provider with a patient in the home via
smartphones or tablets. It can also be used for provider
(specialist)-to-provider consultations in remote areas, for example.
Telehealth carts also exist in healthcare settings and can be used not
only to import care, but also to limit healthcare workers’ exposure to
the virus by using a cart in the isolation room. We see patients
primarily through live video interactions, but we also can fall back to
informed telephone calls, synchronous chatting for therapy and
asynchronous secure messaging for ongoing communications.
The use of symptom trackers and chatbots is another promising area
for coronavirus response. These technologies allow algorithms to be
created and adjusted as more is learned about the coronavirus. These
bots interact with patients and can perform assessments, triage and
ongoing support. The bots can even escalate an interaction to a
telehealth encounter or refer the patient for in-person care.
Finally, home monitoring and medical tricorders are another promising
approach to care. Traditional remote patient monitoring has established
value for managing certain chronic conditions, but the next wave of
home monitoring includes consumer devices like smartwatches (like
the Apple Heart Study), home TVs, and home medical tricorders
like Tytocare that can perform a remote examination. These tools aid
clinicians and patients and provide more robust health data conveniently
from the home setting. Providers can also use the data generated to
better care for the patient or regularly monitor certain conditions.
Q. What must care providers know about telehealth before using it to deal with the coronavirus?
A. Providers must know and understand their role in
this or any other healthcare crisis. They should be well informed and
trained to follow current CDC or World Health Organization guidelines.
They should also understand that telehealth is a powerful tool for
helping fight this outbreak. And they should know that telehealth is a
safe way to treat and/or triage these patients. Whether the provider is a
primary telehealth provider or is not using telehealth today, there is a
real opportunity to participate and play a role in the response.
Providers who have a brick-and-mortar practice should be encouraged
to use telehealth as a triage tool. Providers also need to understand
that during this time, patients with other non-respiratory conditions
also need care. These patients should be afforded a safe way to access
care without risk of infection. Telehealth is also a tool to aid in this
process, as some patients are fearful of going to healthcare facilities
right now. The office-based provider can likewise process other
patients by practicing this way.
Q. What are the barriers or challenges associated with using telehealth to deal with the coronavirus scare?
A. Telehealth visits are typically sufficient to
complete a robust initial assessment. This allow the provider to assign a
risk category, make other diagnoses, or deem the patient as “worried
well.†Some patients may require additional care, as most telehealth in
the home lacks certain medical peripherals that might be needed. Other
reasons for referral would include a high-risk patient who needs to be
tested or a patient who requires escalation of care due to the severity
of their illness. Telehealth visits are generally sufficient for
screening patients, assigning a risk category, answering questions and
recommending the next steps a patient should take.
The barriers to telehealth—such as instances when the patient and
provider do not yet have a relationship—are easily overcome providers
receive similar training around the use of telehealth and as
longitudinal patient records become more available to guide care.
Occasionally the lack of medical peripherals or the inability to touch
the patient during an exam is a barrier, as some patients need hands on
care (e.g., IV, procedures). We have policies that mitigate these
problems in most cases. However, on occasion, a telehealth patient must
be referred for in-person evaluation.
Q. Is there anything that the CDC or any other government
agency can do to support telehealth adoption to deal with the
coronavirus?
A. It is useful for the CDC (and the WHO) to
highlight the important role of telehealth in this outbreak because it
certifies our role within the broader medical community and raises
awareness about this tool.
It would be helpful if the CDC were to make specific recommendations
to telehealth providers that relate to telehealth evaluation of the
coronavirus and associated referrals, coding and monitoring. It would
also be helpful if the CDC were to play a role in advocacy efforts
focused on government reimbursement, particularly in this emergency
situation. Efforts to increase consumer awareness about telehealth as a
safe option for care also could prove essential. When this outbreak
settles down, we would encourage the CDC and HHS to collaborate around
coronavirus standards of care and preparedness so that patients can
expect telehealth providers to be ideally prepared and well-coordinated
for the next outbreak and so that we can offer high-quality care in this
manner to all Americans.
We also believe that our public health system would benefit greatly
from owning its own telehealth network infrastructure. This would allow
the CDC to better scale up, solve for geography and improve
surveillance. It would even allow its public health workers to use
technology to monitor patients under quarantine in the home, saving
themselves travel and limiting healthcare workers’ exposure.
Q. What more can be done with telehealth in the future to
plan for these types of outbreaks, or to perhaps address them before
they become serious?
A. Much needs to be done throughout our country to
better prepare. We need permanent leaders placed at the U.S. Department
of Health and Human Services, the National Institutes for Health, the US
Department of Homeland Security and other key areas, and we need to
reinstate a pandemic-preparedness role at the National Security Council.
We need to fund international efforts to improve screening and research
for emerging diseases, and we need surveillance programs and good
international coordination. We need to fund (not decrease funding) for
our frontline groups, like the CDC, HHS and local public health
services. These are our fighters, and we need them ready and funded
properly as an outbreak like this is a national security issue. We need
stockpiles of materials. Finally, we should be partnering with the
pharmaceutical industry on affordable medications and vaccine research.
Our national telehealth operation today acts like an emergency alert
system. We see cases or potential cases before they are reported. At
American Well, our influenza activity indicator map is more accurate and
more timely than that of the CDC. We already play a meaningful role in
many disease states, including outbreaks. There are still many adoption
and awareness challenges that exist when it comes to telehealth.
Hopefully this unfortunate event will help consumers, providers and
others start to more clearly see how they can and should use telehealth
for future healthcare needs.
Another barrier that we continue to work on is that of reimbursement.
Telehealth is a cost-effective way of receiving care, but it is still
not always a covered benefit by insurance. Most commercial plans are
reimbursing and there is increasing adoption in Medicare Advantage and
Medicaid managed care. But there are still gaps, including a big gap in
fee-for-service coverage for Medicare coverage in the home. Efforts at
reform are underway (see the CONNECT Act), but more work needs to be done so that all Americans can take advantage of this amazing service.
Additionally, with coordination being so important during outbreaks
like this, the simple step of integrating telehealth with other health
information systems, such as EHRs or clinical-decision support, can make
care more seamless and foster better care coordination. This would
speed up access to critical care. Case in point: Consider a scenario
where a patient consults with a physician over a telehealth network and
displays symptoms of COVID-19 while presenting one or more correlating
risk factors. The physician could easily document the experience,
dispatch an alert to a local ED, and ensure precautions are taken by
medical staff to usher this patient into a contained room or unit to
begin testing and treatment. We’re working to ensure this type of
communication is happening at all levels, but there’s still much room
for improvement on this front.
Health System Execs Respond to the Threat
In an op-ed prepared for the Alliance for Connected Care, Todd J.
Vento, MD, MPH, Intermountain Healthcare’s Medical Director of
Infectious Diseases Telehealth Service; Ethan Booker, MD, Medical
Director of MedStar’s Telehealth Innovation Center; and Lawrence “Rustyâ€
Hofmann, MD, Stanford Health’s Medical Director of Digital Health, made
their pitch for telehealth:
“Telehealth, which has proven to be a very useful tool in
addressing patient needs during flu season, will improve our collective
ability to address COVID-19 if it hits on a larger scale. Telehealth offers several advantages over in-person care in the event of a pandemic.
One key advantage of telehealth is speed,†the three wrote.
“Patients can access clinicians 24/7 without an appointment or physical
trip to the doctor. Using telehealth, our providers in the Stanford
Primary Care team, MedStar Health and Intermountain Healthcare have been
actively evaluating and treating patients with influenza. Current
providers at Stanford Health estimate that almost 50% of patients are
getting oseltamivir (Tamiflu). Because there is no current,
specific medication for Coronavirus, we must be able to advise patients
of reasonable self-directed treatment and surveillance to keep them
home.
Keeping patients at home is a significant advantage of
telehealth. In-home video visits limit community exposure by allowing
patients to avoid contact with other patients in waiting rooms and
direct contact with providers during the exam. Our health systems have
providers who are equipped to work from their own homes, significantly
increasing the safety of providers and bolstering the workforce to
respond to crisis. Workforce readiness in a crisis that may include
such dramatic measures as school and day care closures is a significant
concern for health systems which may be strained to respond. Health
systems are also using telehealth to continue surveillance of patients
already identified as at risk while keeping them at home.
Next, telehealth ensures that treatment in brick-and-mortar
settings is reserved for high-need patients. Moreover, with patients
being seen in their own homes, providers and health systems will be able
to triage and screen exponentially more patients with telehealth vs. an
in-person visit.
Finally, telehealth allows patients who do not have access to
infectious diseases (ID) specialists to access this specialized care
from the small number of experts across the country. When Intermountain
first offered ID telehealth consultation to rural systems throughout the
west, one provider fielded 1,000 consultation requests in the first
fifteen months. To date, the service has provided telehealth care to
over 4,700 patients, 50 percent of whom are over 65 years old.
Each of these advantages illustrate how telehealth can thwart the
spread of COVID-19 and stop it from overwhelming our already stretched
medical system.â€
The three health executive also urged lawmakers to take action to reduce barriers to telehealth that have kept adoption low:
“Congress must act to ensure that seniors – a particularly
vulnerable population generally and for this virus in particular – are
able to receive necessary triage and care through telehealth.
Today, there are restrictions in Medicare that prevent providers
outside of very rural areas from being paid for care provided through
telehealth. As a result, many providers do not offer telehealth services
to seniors. The lack of reimbursement creates a perverse incentive of
encouraging patients to come for in-person care, which will only
overwhelm our health system as well as augment the virus’s spread.
Congress must give the Secretary of Health and Human Services the
ability to waive these restrictions in times of public health
emergencies. As part of the bipartisan, bicameral CONNECT for Health
Act, telehealth champions in Congress foresaw this need and drafted a
provision that would give the Secretary the ability to waive telehealth
restrictions just as he/she would waive Conditions of Participation,
Stark Laws licensure, or other requirements when public health
emergencies are declared.â€
Posted by AGORACOM-JC
at 5:12 PM on Thursday, March 12th, 2020
SPONSOR: BetterU Education Corp.
aims to provide access to quality education from around the world. The
company plans to bridge the prevailing gap in the education and job
industry and enhance the lives of its prospective learners by developing
an integrated ecosystem. Click here for more information.
Edtech firms offer free access to colleges that is impacted by Coronavirus
Beginning Thursday, online learning giant Coursera said it is going
to provide every impacted university in the world free access to its
course catalogue through ‘Coursera for Campus’ until July 31
Beginning Thursday, online learning giant Coursera said it is going to provide every impacted university in the world free access to its course catalogue through ‘Coursera for Campus’ until July 31.
Online education companies in India and globally are offering their paid programmmes to students — whether in school or pursuing higher education — free of cost because of the COVID-19 pandemic.
Beginning Thursday, online learning giant Coursera said it is going to provide every impacted university in the world free access to its course catalogue through ‘Coursera for Campus’ until July 31.
“We’re going to make ‘Coursera for
Campus’ offering freely available to any college or university in the
world that is impacted by coronavirus, in the hope that they can rapidly
allow students to start learning and ensure we have minimal impact from
coronavirus on the student community,†said Leah Belsky, chief enterprise officer and senior vice-president, Coursera.
Coursera, founded by Stanford Professors Andrew Ng and Daphne Koller,
has 48 million registered learners worldwide and offers courses,
specialisations, degrees, and certificate programmes online.
The ‘Coursera for Campus’ offers job-relevant online education to
students, alumni, faculty, and employees of firms like Mindtree, Tata
Communications, Axis Bank, Infosys, Airtel, and Manipal Group.
Indian universities can continue teaching their students online
without creating new infrastructure. Coursera’s existing ‘Coursera for
Campus’ partners include Manipal Academy of Higher Education, UPES, Shiv
Nadar University, KL University, NMIMS, and Pearl Academy.
In India, it has 5 million registered learners, and is adding over 100,000 learners per month.
Universities can sign up to provide their enrolled students with
access to more than 3,800 courses and 400 specialisations from
Coursera’s top university and industry partners.
Similarly, Indian education technology firms are also offering free
classes and course material for students impacted by the novel coronavirus. On Wednesday, the World Health Organization declared COVID-19 a global pandemic.
Edtech firm Byju’s also said it will provide free access to its complete app to school students till the end of April.
Some Indian states like Kerala, Karnataka and New Delhi have already announced the closure of schools.
A UNESCO report
states that the education of over 290 million students across 13
countries will be interrupted because of the COVID-19 pandemic.
Another edtech platform Unacademy said it will conduct close to
20,000 free live classes on its platform, across exam categories like
UPSC, banking, railways and so on.
Unacademy claims it has 10,000 educators, 13 million learners, and subscriptions for over 30 exam categories.
Educational Initiatives, a 20-year old edtech company based out of
Bengaluru is also offering 60 days free access of Mindspark to all
students, so that the school closure due to COVID-19 does not impact
their learning.
Mindspark is an artificial intelligence-powered specialised mathematics programme developed for children’s learning.
Similarly, edtech firm Toppr is going to provide free live classes to students in classes 5 to 12.
While it is yet to be seen how effective these measures will be,
Coursera’s Belsky said the US education system invested in digitising
after events like Hurricane Katrina, which forced school and college
students to miss studies for months.
According to some estimates, in New Orleans alone, 110 of the 126
public schools were completely destroyed and students had to be moved to
neighbouring states to complete their education.